Vizex Investments Ltd
financial consultations

Last news

Transenterix announces 1st US sale

Nov 13, 2017 14
November 13th. Transenterix Inc…

We no longer recommend Array Biopharma Inc

Nov 11, 2017 10
November 11th 2017. We are withdrawing…

Transenterix announces Q1 2017 results

May 10th 2017 Transenterix Inc announced finanical results and business update for Q1 2017.  The financial results included

-Sale of 1 Senhance robot in Germany

-$24M offering 

-$17M new credit line that allowed the company to refinance all existing debt.


The company has about $48M in cash which is enough to fund operations through Q2 2018 including launch of the Senhance sales in the U.S. if the robot is approved by the FDA


The company continued building sales infrastrucutre in Europe.  In total the Company placed 7 robots for demo and training purposes covering the major markets - the U.K., Germany, France, and Italy.



Вайзекс Инвестментс ООД © 2015 | Всички права запазени